|
CCNYL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.635200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.136020E-01 |
| Normal-vs-Stage2 |
8.968400E-01 |
| Normal-vs-Stage3 |
1.276210E-01 |
| Normal-vs-Stage4 |
2.041800E-02 |
| Stage1-vs-Stage2 |
3.398000E-01 |
| Stage1-vs-Stage3 |
2.363700E-03 |
| Stage1-vs-Stage4 |
3.411200E-04 |
| Stage2-vs-Stage3 |
4.263400E-01 |
| Stage2-vs-Stage4 |
1.948240E-01 |
| Stage3-vs-Stage4 |
4.612000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.413200E-01 |
| Normal-vs-AfricanAmerican |
9.651600E-02 |
| Normal-vs-Asian |
1.035560E-01 |
| Caucasian-vs-AfricanAmerican |
7.413900E-02 |
| Caucasian-vs-Asian |
2.788400E-01 |
| AfricanAmerican-vs-Asian |
6.840400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.152400E-01 |
| Normal-vs-Female |
1.413620E-01 |
| Male-vs-Female |
4.895200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.695200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.746000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.871600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.899800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.920600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.197400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.352600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.568200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.156600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.224200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.903780E-01 |
| Normal-vs-Grade 2 |
5.890400E-02 |
| Normal-vs-Grade 3 |
3.098800E-01 |
| Normal-vs-Grade 4 |
2.621100E-04 |
| Grade 1-vs-Grade 2 |
4.328800E-01 |
| Grade 1-vs-Grade 3 |
3.901800E-02 |
| Grade 1-vs-Grade 4 |
8.801300E-04 |
| Grade 2-vs-Grade 3 |
2.375400E-03 |
| Grade 2-vs-Grade 4 |
1.09260000047406E-07 |
| Grade 3-vs-Grade 4 |
3.677600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.90310000003358E-06 |
| Normal-vs-ccB subtype |
1.64690999999717E-05 |
| ccA subtype-vs-ccB subtype |
1.62470037423645E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.485400E-01 |
| Normal-vs-N1 |
1.310180E-01 |
| N0-vs-N1 |
1.949620E-01 |
|
|
